Search for: "Federal, Inc."
Results 1141 - 1160
of 57,563
Sorted by Relevance
|
Sort by Date
21 Nov 2018, 5:26 am
In Ancora Technologies, Inc. v. [read post]
2 Sep 2014, 9:41 pm
By Michael Greenfield -- In a not particularly well-written opinion that breaks no new ground, the Federal Circuit considered a consolidated appeal of two patents directed to methods of promoting hair growth, including, in particular, eyelash hair growth using compounds and analogs that were previously known for their utility in treating glaucoma. [read post]
12 Jun 2015, 1:54 pm
CLS Bank in 2015, the Federal Circuit has once again shot down claims for not meeting the patent-eligibility requirements of 35 U.S.C. [read post]
4 Aug 2019, 9:18 pm
By Michael Borella -- On July 23, 2019, the Federal Circuit denied ChargePoint's request for panel rehearing and en banc review of its March 28, 2019 decision rendering four ChargePoint patents invalid under 35 U.S.C. [read post]
22 Jun 2015, 9:59 pm
Such is a reasonable reaction to the Federal Circuit's decision on June 12th in the Ariosa v. [read post]
1 May 2013, 9:59 pm
Earlier today, the Federal Circuit determined in Allergen v. [read post]
11 Jul 2016, 9:59 pm
By Andrew Williams -- Last year, the Federal Circuit described the Biologics Price Competition and Innovation Act ("BPCIA") as "a riddle wrapped in a mystery inside of an enigma" in the Amgen v. [read post]
14 Oct 2015, 9:59 pm
Noonan -- Last week the Federal Circuit affirmed a District Court's finding of invalidity and non-infringement in ANDA litigation between Spectrum Pharmaceuticals and Sandoz. [read post]
27 Dec 2018, 8:42 pm
Sequenom decision a few years ago, Judge Illston has rarely seen a patent she likes (or is not willing to invalidate), and the Supreme Court and Federal Circuit's recent § 101 jurisprudence has given district... [read post]
14 Aug 2013, 9:23 pm
Noonan -- The Federal Circuit vacated and remanded a District Court decision denying a preliminary injunction to patentee Sequenom over the claims of U.S. [read post]
16 Feb 2023, 9:34 pm
Noonan -- Minerva and Hologic, competitors selling devices used for ablating uterine endometrial tissue, are notable for their dispute last year that gave the Supreme Court an opportunity to reassess an established patent law doctrine, assignor estoppel (reminiscent of the Court's review of the Federal Circuit's standard for obviousness in KSR Int'l v. [read post]
27 Apr 2015, 9:59 pm
Noonan -- The Federal Circuit considered the question of indefiniteness on remand from the Supreme Court's reversal in Nautilus v. [read post]
8 Dec 2006, 8:45 am
Have you ever heard of the company ChoicePoint, Inc.? [read post]
27 Jul 2020, 8:57 pm
AT&T Services, Inc. [read post]
3 Nov 2006, 1:45 pm
Posted by Ronald LondonThe Federal Trade Commission announced that it has reached a settlement with mortgage services company USA Home Loans Inc., and its telemarketer USA First Investment Group, Inc., over alleged violations of the agency’s Telemarketing Sales Rule (“TSR”)... [read post]
11 Dec 2013, 10:00 pm
Tolmar, Inc., the Federal Circuit reversed the district court’s findings that the Orange Book-listed patents for Galderma’s Differin® 0.3% gel product were not invalid as obvious. [read post]
2 Apr 2007, 8:37 pm
In procedural matters (eBay Inc. v. [read post]
9 Apr 2012, 4:00 pm
Hospira, Inc., the Federal Circuit upheld the district court’s finding that two of the Orange Book listed patents for Sanofi Aventis’ cancer drug Taxotere are unenforceable for inequitable conduct. [read post]
28 May 2010, 12:08 pm
On June 9, 2010, the Federal Circuit is scheduled to hear oral argument in Spansion, Inc. v. [read post]
6 Jul 2012, 8:55 am
NextCare Inc., an Arizona based owner of urgent care medical facilities, has settled False Claims Act allegations brought against the company by the Department of Justice. [read post]
